Skip to main content
. 2020 May 13;18(5):e06113. doi: 10.2903/j.efsa.2020.6113

Table E.1.

In vitro studies on biotransformation of OTA

Experimental system Species Purity of OTA Metabolites Analytical method Structure confirmation Comment Reference
Liver microsomes Rabbit, human, pig 4(R)‐HO‐OTA;4(S)‐HO‐OTA TLC MS, NMR Enzyme kinetics (Vmax + KM) Størmer et al. (1981)
Liver microsomes +/− phenobarbital Rabbit Not specified 4(R)‐HO‐OTA; 4(S)‐HO‐OTA; 10‐HO‐OTA

TLC

HPLC‐UV

MS, NMR Enzyme kinetics (Vmax + KM) Størmer et al. (1983)
Kidney cells (Vero cells) Monkey Not specified OTalpha; 4(R)‐HO‐OTA; 4(S)‐HO‐OTA; OTB HPLC‐FLD No kinetics Grosse et al. (1995)
Kidney microsomes +/− phenobarbital Rabbit Not specified

4(R)‐HO‐OTA; 4(S)‐HO‐OTA

10‐HO‐OTA; OTB; 3 unidentified metabolites

HPCL‐FLD No kinetics El Adlouni et al. (2000)
Bronchial epithelial cells +/− phenobarbital Human Not specified OTalpha; 4(R)‐HO‐OTA; 4(S)‐HO‐OTA; 10‐HO‐OTA; OTB; 3 unidentified metabolites
Liver microsomes +/− GSH and cytosol Rat ♂♀ [U‐3H]OTA (18 Ci/mmol) radiochemical purity > 98% 4(R)‐HO‐OTA HPLC‐radioactivity detector MS, NMR Enzyme kinetics (Vmax) Gautier et al. (2001)
Liver microsomes +/− GSH and cytosol Human 4(R)‐HO‐OTA No evidence of GSH conjugates
Liver S‐9 +/− GSH Rat 4(R)‐HO‐OTA No evidence of GSH conjugates
Kidney microsomes +/− GSH and cytosol Rat, Human No evidence of GSH conjugates
CYP1A1, 1A2, 2E1, 3A4 Human 4(R)‐HO‐OTA
CYP1A2, 2C11 Rat
Seminal vesicle microsomes Ram Unidentified metabolite
Seminal vesicle microsomes enriched in prostaglandin H‐synthase Horseradish peroxidase
Liver microsomes +/− inducers of CYPs Rat, mice ♂♀ > 99% (HPLC) 4(R)‐HO‐OTA; 4(S)‐HO‐OTA HPLC‐FLD MS/MS Enzyme kinetics (Vmax + KM) Zepnik et al. (2001)
CYP1A2, 2C9‐1, 3A4 supersomes® a Human > 99% (HPLC) 4(R)‐HO‐OTA; 4(S)‐HO‐OTA MS/MS Enzyme kinetics (Vmax)
Semipurified GSTs +/− liver and kidney cytosol Rat > 99% (HPLC) 4(R)‐HO‐OTA; 4(S)‐HO‐OTA MS/MS Enzyme kinetics (Vmax)
Kidney microsomes or cytosol fortified with NADPH and GSH; Liver cytosol Rat > 99% (HPLC)

Horseradish peroxidase/H2O2

Soybean lipoxygenase

> 99% (HPLC)
Primary hepatocytes +/− induction by 3‐methylcholanthrene Rat, human 3H‐OTA (0.6 Ci/mmol)

4(R)‐HO‐OTA; OTA‐hexose

OTA‐pentose

HPLC‐radioactivity detection/quantification system MS/MS No effect of β‐Gluc, sulfatase or GGT on metabolite retention times, suggesting that phase‐II‐conjugates were not formed Gross‐Steinmeyer et al. (2002)
Liver microsomes Rat Not specified 4‐HO‐OTA; OTHQ‐GSH LC‐MS/MS OTHQ‐GSH generated in less than 1% yield Dai et al. (2002)
Horseradish peroxidase/H2O2
Fe2(NH4)2(SO4)2/H2O2 OTHQ‐GSH
Kidney cells Opossum Not specified

OTalpha; 4(R)‐HO‐OTA

4(S)‐HO‐OTA; OTB; OTHQ; OP‐OTA; Several unidentified metabolites

HPLC‐FLD

nano‐ESI‐IT‐MS

No kinetics Faucet‐Marquis et al. (2006)
Liver microsomes Rat, human, pig, cow, chicken, goat 99%

4(R)‐HO‐OTA; 4(S)‐HO‐OTA

Hydroxylated metabolites tentatively identified as 9′‐HO‐OTA: 7′‐HO‐OTA, 5′‐HO‐OTA; OTB

UPLC‐Q/TOF‐MS

No enzyme kinetics

No OTA‐derived glucuronides detected

Yang et al. (2015)

GGT:γ‐glutamyltranspeptidase; β‐Gluc:β‐glucuronidase; GSH: glutathione; HO‐OTA: hydroxy ochratoxin; HPLC‐FLD: high‐performance liquid chromatography with fluorescence detection; KM:Michaelis constant, concentration of substrate which permits the enzyme to achieve half Vmax; NADPH: nicotinamide adeninedinucleotide phosphate; OTA: ochratoxin A; OTalpha: ochratoxin alpha; OTB: ochratoxin B; OTHQ: ochratoxin hydroquinone; LC‐MS/MS: liquid chromatography‐mass spectrometry and tandem mass spectrometry; MS: mass spectroscopy; nano‐ESI‐IT‐MS: TLC: thin layer chromatography; TLC HPLC‐UV: thin layer chromatography high‐performance liquid chromatography with ultraviolet detection; UPLC‐Q/TOF‐MS: ultra‐high‐performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry; Vmax: maximum velocity of an enzymatic reaction.

a

Corning Supersomes® enzymes are recombinantly expressed drug metabolising enzyme reagents, consisting of microsomes prepared from insect cells infected with a virus engineered to express a CYP isoform.